Microbes in Gastrointestinal Health and Disease

Slides:



Advertisements
Similar presentations
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Advertisements

Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 141, Issue 5, Pages (November 2011)
Volume 141, Issue 5, Pages (November 2011)
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Volume 152, Issue 4, Pages (March 2017)
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 141, Issue 5, Pages (November 2011)
Covering the Cover Gastroenterology
Microbial Influences in Inflammatory Bowel Diseases
Gut Microbiota: Mining for Therapeutic Potential
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Volume 139, Issue 5, Pages (November 2010)
Volume 140, Issue 6, Pages (May 2011)
Is HCV Infection a Neurologic Disorder?
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 154, Issue 5, Pages (April 2018)
Volume 151, Issue 4, Pages (October 2016)
Volume 155, Issue 4, Pages (October 2018)
Volume 134, Issue 5, Pages (May 2008)
Clinical Challenges and Images in GI
Endosomes as Platforms for NOD-like Receptor Signaling
Eamonn M.M. Quigley  Clinical Gastroenterology and Hepatology 
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Probiotics in Perspective
Nod2 in Normal and Abnormal Intestinal Immune Function
Colon Cancer: An Update and Future Directions
Volume 139, Issue 6, Pages (December 2010)
Gastrointestinal Stromal Tumors: Disease and Treatment Update
TFH-IgA Responses Keep Microbiota in Check
Pattern Recognition Receptors
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Volume 146, Issue 7, Pages (June 2014)
Covering the Cover Gastroenterology
Autophagy, Microbial Sensing, Endoplasmic Reticulum Stress, and Epithelial Function in Inflammatory Bowel Disease  Arthur Kaser, Richard S. Blumberg 
The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System  Yuuki Obata, Vassilis Pachnis  Gastroenterology 
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Volume 153, Issue 4, Pages (October 2017)
Helicobacter pylori in Health and Disease
Volume 155, Issue 2, Pages (August 2018)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Homeostasis and Inflammation in the Intestine
Volume 141, Issue 1, Pages (July 2011)
Volume 149, Issue 6, Pages (November 2015)
Volume 150, Issue 7, Pages (June 2016)
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Richard J. Saad, William D. Chey  Gastroenterology 
Volume 151, Issue 4, Pages (October 2016)
Richard Blumberg, Judy Cho, James Lewis, Gary Wu  Gastroenterology 
Volume 147, Issue 4, Pages (October 2014)
Michiel Bronswijk, Gert De Hertogh, Marc Ferrante  Gastroenterology 
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 155, Issue 6, Pages (December 2018)
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
Amir Klein, Michael J. Bourke  Gastroenterology 
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Covering the Cover Gastroenterology
The Tuning of the Gut Nervous System by Commensal Microbiota
Presentation transcript:

Microbes in Gastrointestinal Health and Disease Andrew S. Neish  Gastroenterology  Volume 136, Issue 1, Pages 65-80 (January 2009) DOI: 10.1053/j.gastro.2008.10.080 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Mechanisms of microbiota and gut crosstalk. Both parties in the symbiotic dyad possess means to alter and shape each other, resulting in a “negotiated settlement” at equilibrium. A breakdown on this crosstalk may result in a “dysbiotic” microbiota and clinical consequences. Gastroenterology 2009 136, 65-80DOI: (10.1053/j.gastro.2008.10.080) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Cellular consequences to bacterial stimuli. Bacterial MAMPs may stimulate pattern recognition receptors (including extracellular TLRs and formylated peptide receptors, or intracellular Nods). Intensity, duration, and spatial origin of the subsequent signaling responses are integrated by an intricate and interrelated network of transduction pathways that determine if MAMP perception warrants a “low gain” cytoprotective response, a “medium gain” inflammatory reaction, or “high gain” programmed cell death result. Gastroenterology 2009 136, 65-80DOI: (10.1053/j.gastro.2008.10.080) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Preferred sites of commensal/probiotic interaction with the gut. Cecum/ascending colon is a “bioreactor” with the greatest amounts of bacteria, metabolic activity, and SCFA fermentation. Concentration of SCFA diminishes along the colon. The distal ileum is enriched in GALT (Peyer's patches) and is the dominant site of luminal sampling and mucosal adaptive immune activity. Gastroenterology 2009 136, 65-80DOI: (10.1053/j.gastro.2008.10.080) Copyright © 2009 AGA Institute Terms and Conditions